A promising new treatment approach for major depressive disorder (MDD) targets the
microbiota-gut-brain (MGB) axis, which is linked to physiological and behavioral functions affected …

Depression is a debilitating disorder, and at least one third of patients do not respond to
therapy. Associations between gut microbiota and depression have been observed in recent …

Background: In major depressive disorder (MDD), cognitive dysfunctions strongly contribute
to functional impairments but are barely addressed in current therapies. Novel treatment …

Background Probiotics are suggested to improve depressive symptoms via the microbiota-gut-brain
axis. We have recently shown a beneficial clinical effect of probiotic supplementation …

Anhedonia has been associated with abnormal reward-related striatal dopamine functioning
in patients with different psychiatric disorders. Here, we tested whether anhedonia …

We recently indicated that four-week probiotic supplementation significantly reduced
depression along with microbial and neural changes in people with depression. Here we further …

Background There is urgent need to develop novel augmentation options for improving
inadequate response to antidepressants. Emerging evidence showed that the composition of the …

A 39-year-old female patient suffering from severe, treatment-resistant depression and other
symptoms associated with a complex personality disorder was admitted to our open …

Objectives: Aggressive angiomyxoma is known as a mesenchymal tumor of premenopausal
women and it is extremely rare in men. Methods: Herein, we report a 66-year-old male with …

La réhabilitation précoce est une approche multidisciplinaire de la période postopératoire
visant au rétablissement rapide des capacités physiques et psychiques antérieures d’un …